Literature DB >> 10366137

Prevention of varicella. Update recommendations of the Advisory Committee on Immunization Practices (ACIP).

.   

Abstract

In February 1999, the Advisory Committee on Immunization Practices (ACIP) expanded recommendations for varicella (chickenpox) vaccine to promote wider use of the vaccine for susceptible children and adults. The updated recommendations include establishing child care and school entry requirements, use of the vaccine following exposure and for outbreak control, use of the vaccine for some children infected with the human immunodeficiency virus (HIV), and vaccination of adults and adolescents at high risk for exposure. These recommendations also provide new information on varicella vaccine postlicensure safety data.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10366137

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  33 in total

1.  Purple spots and chickenpox.

Authors:  R Usatine
Journal:  West J Med       Date:  2000-11

Review 2.  25 years' experience with the Biken Oka strain varicella vaccine: a clinical overview.

Authors:  M Takahashi
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 3.  [Immunization: Leaps into the future. Foreseeable changes in children's vaccination calendar in the coming years].

Authors:  J Pericas Bosch
Journal:  Aten Primaria       Date:  2003-03-31       Impact factor: 1.137

4.  Stable and consistent genetic profile of Oka varicella vaccine virus is not linked with appearance of infrequent breakthrough cases postvaccination.

Authors:  Ventzislav Vassilev
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

5.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

6.  Presumptive varicella vaccination is warranted in Greek adolescents lacking a history of disease or household exposure.

Authors:  Alexandra Katsafadou; Konstantina Kallergi; George Ferentinos; Theodora Goulioti; Maria Foustoukou; Vassiliki Papaevangelou
Journal:  Eur J Pediatr       Date:  2008-04-05       Impact factor: 3.183

7.  Prevalence and Persistence of Varicella Antibodies in Previously Immunized Children and Youth With Perinatal HIV-1 Infection.

Authors:  Murli U Purswani; Brad Karalius; Tzy-Jyun Yao; D Scott Schmid; Sandra K Burchett; George K Siberry; Kunjal Patel; Russell B Van Dyke; Ram Yogev; Robert H Lurie; Ram Yogev; Margaret Ann Sanders; Kathleen Malee; Scott Hunter; William Shearer; Mary Paul; Norma Cooper; Lynnette Harris; Murli Purswani; Mahboobullah Baig; Anna Cintron; Ana Puga; Sandra Navarro; Patricia Garvie; James Blood; Sandra Burchett; Nancy Karthas; Betsy Kammerer; Andrew Wiznia; Marlene Burey; Molly Nozyce; Arry Dieudonne; Linda Bettica; Susan Adubato; Janet Chen; Maria Garcia Bulkley; Latreaca Ivey; Mitzie Grant; Katherine Knapp; Kim Allison; Megan Wilkins; Midnela Acevedo-Flores; Heida Rios; Vivian Olivera; Margarita Silio; Medea Jones; Patricia Sirois; Stephen Spector; Kim Norris; Sharon Nichols; Elizabeth McFarland; Alisa Katai; Jennifer Dunn; Suzanne Paul; Gwendolyn Scott; Patricia Bryan; Elizabeth Willen
Journal:  Clin Infect Dis       Date:  2015-09-18       Impact factor: 9.079

Review 8.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

Review 9.  Optimal timing of routine vaccination in HIV-infected persons.

Authors:  Heidi M Crane; Shireesha Dhanireddy; H Nina Kim; Christian Ramers; Timothy H Dellit; Mari M Kitahata; Robert D Harrington
Journal:  Curr HIV/AIDS Rep       Date:  2009-05       Impact factor: 5.071

10.  The epidemiology of varicella in school-aged Greek children before the implementation of universal vaccination.

Authors:  A Katsafadou; G Ferentinos; A Constantopoulos; V Papaevangelou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11-16       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.